{"id": "1384279567641157638", "creation": 1618872942.0, "user_id": "1265067408454062080", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "quoted": "1384275134790262785", "text": "in @TheLancetInfDis now. \n#Researchpaper on  the \"safety and immunogenicity of an MF59-adjuvanted subunit #vaccine for COVID-19 based on recombinant SARS-CoV-2 spike #glycoprotein\" by @UQ_News @ProfPaulYoung numerous collaborators.\n\n#COVID19 #SARSCoV2 #MedTwitter #BiomedTwitter https://t.co/DMmQcQ6n18", "first_save": 1634559108.199414, "hashtags": ["#RESEARCHPAPER", "#VACCINE", "#GLYCOPROTEIN", "#COVID19", "#SARSCOV2", "#MEDTWITTER", "#BIOMEDTWITTER"]}